According to our research report “Indian Pharma Sector Forecast 2014”, the pharmaceutical industry in the country has been growing at a fast pace on the back of several supportive factors, such as growing population and rapid urbanization. Moreover, increase in lifestyle-related diseases, such as diabetes and cardiovascular diseases are contributing to the rising demand for drugs in India. Although the affordability of drugs by majority of the population was a concern earlier, acceptance of the health insurance schemes has allowed the people to even opt for the expensive therapies. As a result of the persistence of these factors in future also, the domestic pharmaceutical industry in India is expected to grow at a CAGR of around 15% during FY 2012-FY 2014.
Growth in the industry will largely be based on the sale of generic drugs, which are equally effective yet cheaper than the branded drugs. Considering the low spending power of India, the generics segment has become the lifeline of the pharma industry and is being supported greatly by the government also. Additionally, emerging sectors, such as biogenerics, bioinformatics, clinical trials, and pharma outsourcing will help the pharmaceutical market to continue its upward trend during the forecast period.
We have done an extensive research and analysis of various segments of the Indian pharmaceutical market. These segments include: Domestic & Export Market, Branded & Generics Drugs, Formulations & Bulk Drugs, etc. Besides, we have included a study on acute and chronic therapeutic segments of the industry. The comprehensive information about past, present, and future trends, with focus on entire structure, composition, and working of the pharmaceutical market are an add-on in the report.
Our report “Indian Pharma Sector Forecast 2014”, also analyzes the regulatory environment and distribution system to identify strengths and weaknesses of the pharmaceutical market. It has thoroughly examined current market trends, industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years. It also presents a brief overview of the demographics and healthcare profile to adjudge the pharmaceutical market in terms of demand, expenditure, and possible future direction.
For more information visit: http://www.rncos.com/Report/IM323.htm |
